Ivabradine: first of a new class of treatments for angina

  • Doig C
N/ACitations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Ivabradine is the first selective sinus node inhibitor for use in the treatment of angina. In this article Dr Doig describes its novel mode of action and the results of clinical trials of its efficacy and safety. Copyright © 2006 Wiley Interface Ltd

Cite

CITATION STYLE

APA

Doig, C. (2006). Ivabradine: first of a new class of treatments for angina. Prescriber, 17(15), 14–17. https://doi.org/10.1002/psb.404

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free